BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Public Health England (PHE) awarded the contract for the Borrelia miyamotoi antigens (GlpQ and Vlp15/16) for its South West Regional Laboratory to The Native Antigen Company.
If you feel that you can meet the above requirements or would like more information, then please access the tender documents via link: https://phe.bravosolution.co.uk/
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| The Native Antigen Company Limited | 07386339 | £15,000 | - |
Government spending data: This supplier has received £55,949 in 5 payments (over £25k) from Department of Health and Social Care (2021-03-29 to 2021-03-29). View full payment history →